According to filings with the U.S. Securities and Exchange Commission, OurPharma is raising $17,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Peter Kohler played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About OurPharma
OurPharma is a Fayetteville, Arkansas based DEA and FDA-registered 503B outsourcing facility committed to providing high-quality compounded sterile preparations to healthcare organizations across the United States. Founded by former hospital and healthcare executives, OurPharma recognizes the impact on the healthcare supply chain from not having trusted and reliable suppliers to provide essential medications for patients. To further understand the supply issues with compounded preparations, OurPharma prioritizes collaboration with hospitals, surgery centers, and other organizations seeking a supplier looking to make a difference in the lives of patients. Through a cGMP compliant and purpose-built outsourcing facility, OurPharma is improving the standards of the 503B industry and reinventing the definition of a commitment to quality-driven culture.

To learn more about OurPharma, visit http://ourpharma.net/

Contact:
Peter Kohler, Chief Executive Officer
479-871-7341
https://www.linkedin.com/in/peter-o-kohler-73484329/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.